PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1718682-2	1991	Formoterol, a long-acting beta 2-selective adrenoceptor agonist, produces dose-proportional bronchodilation in patients with obstructive airways disease with a reversible component.	Formoterol Fumarate	0-10	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	26-32	
1718682-15	1991	The long-acting beta 2-agonists, including formoterol, represent a significant advance over current maintenance or prophylactic bronchodilator therapy with intermediate-acting beta 2-agonists such as salbutamol, fenoterol and terbutaline, predominantly because of the twice daily administration regimen.	Formoterol Fumarate	43-53	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	16-22